<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01158573</url>
  </required_header>
  <id_info>
    <org_study_id>36879</org_study_id>
    <nct_id>NCT01158573</nct_id>
  </id_info>
  <brief_title>Role of Cysteinyl Leukotrienes in the Pathogenesis of Asthma in Obesity</brief_title>
  <official_title>Role of Cysteinyl Leukotrienes in the Pathogenesis of Asthma in Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Michigan</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine whether there are higher levels of cysteinyl
      leukotrienes in obese subjects than in non-obese subjects. Cysteinyl leukotrienes are
      pro-inflammatory substances that cause asthma by narrowing the airways of the lung. The
      investigators want to see if subjects with increased fat stores and therefore increased
      leptin, which is a fat-related protein that regulates leukotrienes, have increased levels of
      leukotrienes in the blood, lung and urine. The investigators would also like to determine the
      relationship between cysteinyl leukotrienes and exhaled nitric oxide levels in asthmatics
      with and without obesity. Nitric oxide is anti-inflammatory and suppresses leukotriene
      synthesis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a cross-sectional observational study to characterize the association between obese
      asthmatics and the inflammatory mediators cysteinyl leukotrienes. Our hypothesis is that
      altered adipokine levels in obesity result in augmented cysteinyl leukotriene synthesis that
      play a significant role in the pathogenesis of asthma in these subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2010</start_date>
  <completion_date type="Actual">May 2013</completion_date>
  <primary_completion_date type="Actual">May 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma Leptin</measure>
    <time_frame>Observational: one time point from a blood draw after more than 6 hours fasting</time_frame>
    <description>Measurement of plasma leptin in obese and non obese asthmatics and non-asthmatic subjects from a single blood draw.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exhaled Nitric Oxide (FeNO)</measure>
    <time_frame>Observational: Two exhalations within 1 minute</time_frame>
    <description>Exhaled breath nitic oxide ppb (averaged values from 2 exhalations per participant)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Urine Cysteinyl Leukotriene Per Creatinine</measure>
    <time_frame>sample taken over 5 minutes or less</time_frame>
    <description>Urine inflammatory mediators measured from a single urine sample</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Ratio U Cys-LT/FeNO</measure>
    <time_frame>sample taken over 5 minutes or less</time_frame>
    <description>Responsiveness to leukotriene modifier medication by measuring the urine cysteinyl leukotriene/exhaled nitric oxide ratio</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">117</enrollment>
  <condition>Asthma</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Healthy non-asthmatic obese adults</arm_group_label>
    <description>Healthy non-asthmatic obese adults</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy non-asthmatic non-obese adults</arm_group_label>
    <description>Healthy non-asthmatic non-obese adults</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asthmatic obese adults</arm_group_label>
    <description>Asthmatic obese adults</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Asthmatic non-obese adults</arm_group_label>
    <description>Asthmatic non-obese adults</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Subjects will provide 30 cc of blood, a urine sample and we will collect 1-2 ml. of exhaled
      breath condensate for analysis.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        UM Housing Residents/Student Dorms UM Human Research Recruiting Registry (e.g., ENGAGE -
        http://www.med.umich.edu/engage/) Department or unit-specific research recruiting registry
        (provide UM IRB project number below) Other UM subject pools (describe below) Patients or
        their medical records from the UM Health System or any other UM health care provider (e.g.,
        School of Dentistry, University Health Service, University Center for Language and
        Literacy)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65 yr old adults with asthma, non-smoking for at least one year

          -  Healthy non-smoking adults, aged 18-65 without asthma

          -  Heavy subjects with BMI &gt; 30 kg/m2

          -  Subjects with normal weight (BMI between 20-25 kg/m2)

          -  Subject not taking anti-leukotriene therapy (Singulair, Accolate, Zyflo)

        Exclusion Criteria:

          -  No chronic oral steroid use

          -  No recent history of infection

          -  No recent history of flare of lung disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Coffey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Michigan</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 7, 2010</study_first_submitted>
  <study_first_submitted_qc>July 7, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 8, 2010</study_first_posted>
  <results_first_submitted>December 14, 2015</results_first_submitted>
  <results_first_submitted_qc>June 14, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">January 24, 2018</results_first_posted>
  <last_update_submitted>June 14, 2017</last_update_submitted>
  <last_update_submitted_qc>June 14, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">January 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Michigan</investigator_affiliation>
    <investigator_full_name>Michael Coffey</investigator_full_name>
    <investigator_title>Associate Professor Internal Medicine, Pulmonary Division</investigator_title>
  </responsible_party>
  <keyword>Asthma</keyword>
  <keyword>Obesity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cysteinyl-leukotriene</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>OA Obese Asthma BMI &gt;30
NANO Non asthma non obese
ANO Asthma non obese
NAO Non asthma obese BMI &gt;30
Started July 2010 completed May 2013</recruitment_details>
      <pre_assignment_details>Pre-assignment weight determined and pulmonary function testing prior to enrollment in observational study
One time point study when mediators were mesaured.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Obese Asthma</title>
          <description>Obese Asthma (OA)
BMI &gt; 30 Obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
        </group>
        <group group_id="P2">
          <title>Non Asthma, Non-obese</title>
          <description>BMI 20-25 Non obese</description>
        </group>
        <group group_id="P3">
          <title>Asthma, Non-obese</title>
          <description>BMI 20-25 Non obese</description>
        </group>
        <group group_id="P4">
          <title>Non Asthma, Obese</title>
          <description>BMI .30</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="30">Aimed to recruit 160 from July 2010 to May 2013. Each subject studied on one time point only</participants>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="29"/>
                <participants group_id="P4" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30">Study completed at 117 subjects.</participants>
                <participants group_id="P2" count="30"/>
                <participants group_id="P3" count="29"/>
                <participants group_id="P4" count="28"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
                <participants group_id="P4" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Obese Asthma (OA)</title>
          <description>BMI &gt; 30 Obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
        </group>
        <group group_id="B2">
          <title>Non Asthma Non-obese (NANO)</title>
          <description>BMI 20-25 Non obese</description>
        </group>
        <group group_id="B3">
          <title>Asthma Non Obese (ANO)</title>
          <description>BMI 20-25 Non obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
        </group>
        <group group_id="B4">
          <title>Non Asthma Obese (NAO)</title>
          <description>BMI &gt; 30 Obese</description>
        </group>
        <group group_id="B5">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="30"/>
            <count group_id="B2" value="30"/>
            <count group_id="B3" value="29"/>
            <count group_id="B4" value="28"/>
            <count group_id="B5" value="117"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.0" spread="10.3"/>
                    <measurement group_id="B2" value="31.5" spread="11.6"/>
                    <measurement group_id="B3" value="29.9" spread="9.8"/>
                    <measurement group_id="B4" value="42.7" spread="13.6"/>
                    <measurement group_id="B5" value="37.0" spread="13.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="20"/>
                    <measurement group_id="B4" value="21"/>
                    <measurement group_id="B5" value="77"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="9"/>
                    <measurement group_id="B4" value="7"/>
                    <measurement group_id="B5" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="38.9" spread="6.1"/>
                    <measurement group_id="B2" value="22.9" spread="1.7"/>
                    <measurement group_id="B3" value="22.8" spread="1.7"/>
                    <measurement group_id="B4" value="37.7" spread="5.4"/>
                    <measurement group_id="B5" value="30.8" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Plasma Leptin</title>
        <description>Measurement of plasma leptin in obese and non obese asthmatics and non-asthmatic subjects from a single blood draw.</description>
        <time_frame>Observational: one time point from a blood draw after more than 6 hours fasting</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Obese Asthma (OA)</title>
            <description>BMI &gt; 30 Obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
          </group>
          <group group_id="O2">
            <title>Non Asthma Non-obese (NANO)</title>
            <description>BMI 20-25 Non obese</description>
          </group>
          <group group_id="O3">
            <title>Asthma Non Obese (ANO)</title>
            <description>BMI 20-25 Non obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
          </group>
          <group group_id="O4">
            <title>Non Asthma Obese (NAO)</title>
            <description>BMI &gt; 30 Obese</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Leptin</title>
          <description>Measurement of plasma leptin in obese and non obese asthmatics and non-asthmatic subjects from a single blood draw.</description>
          <units>ng/ml</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="55.4" spread="26.9"/>
                    <measurement group_id="O2" value="8.9" spread="8.8"/>
                    <measurement group_id="O3" value="24.2" spread="12.9"/>
                    <measurement group_id="O4" value="46.5" spread="24.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Hypothesis that leptin levels in OA is not different from the other 3 groups.</p_value_desc>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Exhaled Nitric Oxide (FeNO)</title>
        <description>Exhaled breath nitic oxide ppb (averaged values from 2 exhalations per participant)</description>
        <time_frame>Observational: Two exhalations within 1 minute</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Obese Asthma (OA)</title>
            <description>BMI &gt; 30 Obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
          </group>
          <group group_id="O2">
            <title>Non Asthma Non-obese (NANO)</title>
            <description>BMI 20-25 Non obese</description>
          </group>
          <group group_id="O3">
            <title>Asthma Non Obese (ANO)</title>
            <description>BMI 20-25 Non obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
          </group>
          <group group_id="O4">
            <title>Non Asthma Obese (NAO)</title>
            <description>BMI &gt; 30 Obese</description>
          </group>
        </group_list>
        <measure>
          <title>Exhaled Nitric Oxide (FeNO)</title>
          <description>Exhaled breath nitic oxide ppb (averaged values from 2 exhalations per participant)</description>
          <units>parts per billion (ppb)</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.8" spread="9.3"/>
                    <measurement group_id="O2" value="20.7" spread="14.0"/>
                    <measurement group_id="O3" value="29.5" spread="22.4"/>
                    <measurement group_id="O4" value="19.9" spread="10.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.002</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Urine Cysteinyl Leukotriene Per Creatinine</title>
        <description>Urine inflammatory mediators measured from a single urine sample</description>
        <time_frame>sample taken over 5 minutes or less</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Obese Asthma (OA)</title>
            <description>BMI &gt; 30 Obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
          </group>
          <group group_id="O2">
            <title>Non Asthma Non-obese (NANO)</title>
            <description>BMI 20-25 Non obese</description>
          </group>
          <group group_id="O3">
            <title>Asthma Non Obese (ANO)</title>
            <description>BMI 20-25 Non obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
          </group>
          <group group_id="O4">
            <title>Non Asthma Obese (NAO)</title>
            <description>BMI &gt; 30 Obese</description>
          </group>
        </group_list>
        <measure>
          <title>Urine Cysteinyl Leukotriene Per Creatinine</title>
          <description>Urine inflammatory mediators measured from a single urine sample</description>
          <units>pg/mg creatinine</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.21" spread="3.2"/>
                    <measurement group_id="O2" value="6.35" spread="3.3"/>
                    <measurement group_id="O3" value="6.31" spread="2.65"/>
                    <measurement group_id="O4" value="6.67" spread="3.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.725</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Ratio U Cys-LT/FeNO</title>
        <description>Responsiveness to leukotriene modifier medication by measuring the urine cysteinyl leukotriene/exhaled nitric oxide ratio</description>
        <time_frame>sample taken over 5 minutes or less</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Obese Asthma (OA)</title>
            <description>BMI &gt; 30 Obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
          </group>
          <group group_id="O2">
            <title>Non Asthma Non-obese (NANO)</title>
            <description>BMI 20-25 Non obese</description>
          </group>
          <group group_id="O3">
            <title>Asthma Non Obese (ANO)</title>
            <description>BMI 20-25 Non obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
          </group>
          <group group_id="O4">
            <title>Non Asthma Obese (NAO)</title>
            <description>BMI &gt; 30 Obese</description>
          </group>
        </group_list>
        <measure>
          <title>Ratio U Cys-LT/FeNO</title>
          <description>Responsiveness to leukotriene modifier medication by measuring the urine cysteinyl leukotriene/exhaled nitric oxide ratio</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="30"/>
                <count group_id="O3" value="29"/>
                <count group_id="O4" value="28"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.5" spread="0.4"/>
                    <measurement group_id="O2" value="0.42" spread="0.3"/>
                    <measurement group_id="O3" value="0.3" spread="0.21"/>
                    <measurement group_id="O4" value="0.44" spread="0.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
              <group_id>O4</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.16</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Obese Asthma (OA)</title>
          <description>BMI &gt; 30 Obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
        </group>
        <group group_id="E2">
          <title>Non Asthma Non-obese (NANO)</title>
          <description>BMI 20-25 Non obese</description>
        </group>
        <group group_id="E3">
          <title>Asthma Non Obese (ANO)</title>
          <description>BMI 20-25 Non obese
Asthma based on asthma questionnaire, peak flow meter, spirometry, history, physical examination and medication use.</description>
        </group>
        <group group_id="E4">
          <title>Non Asthma Obese (NAO)</title>
          <description>BMI &gt; 30 Obese</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="29"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="28"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Michael Coffey M.D.</name_or_title>
      <organization>University of Michigan</organization>
      <phone>734-936-6267</phone>
      <email>coffeym@umich.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

